Wolters Kluwer Survey Finds Rising Demand for Trusted Medication Intelligence as Healthcare Adopts AI

By Public Technologies
  • Wolters Kluwer research highlights accelerating healthcare adoption of AI-enabled medication workflows, despite consumer concerns over trust and human oversight.
  • Among healthcare professionals surveyed, 99% report their organizations are moving toward AI-enabled medication workflows.
  • Meanwhile, 98% expect organizational reliance on curated, continually updated medication intelligence to increase as workflows become more automated.
  • Only 27% of consumers strongly trust automated systems to flag potential drug interactions correctly without direct healthcare professional involvement.
  • Reflecting that caution, 68% would independently verify AI-generated medication details always or most of the time.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wolters Kluwer NV published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk